Stage II-IV Lung Cancer Cases with Lymphovascular Invasion Relapse Within 2 Years After Surgery

Overview

Journal Gen Thorac Cardiovasc Surg

Specialties Cardiology & Vascular Diseases
General Surgery
Pulmonary Medicine

Date 2013 Nov 5

PMID 24186264

Citations 3

Authors

Satoshi Shiono

Naoki Kanauchi

Naoki Yanagawa

Masami Abiko

Toru Sato

Affiliations

Soon will be listed here.

Abstract

Objective: For recurrent lung cancer, postoperative follow-up methods have not been adequately assessed, and no evidence-based postoperative surveillance methods currently exist. Herein, we evaluated postoperative lung cancer recurrence and the personalized postoperative surveillance periods and methods used.

Methods: Follow-up after surgery consisted of a regular outpatient clinic check-up, including physical examination, history, blood tests, and chest X-ray, which were conducted three or four times per year for 5 years. During the follow-up period, annual chest and brain computed tomography scanning was performed. Between May 2004 and December 2011, 547 lung cancer patients underwent complete resection in our institution. We retrospectively reviewed their prospectively collected data.

Results: We selected 106 patients (19.4 %) who had a postoperative recurrence. Multivariate analysis showed that advanced stage (stage II-IV; p < 0.01) and lymphovascular invasion positivity (LVI; p = 0.01) were independent risk factors for earlier recurrence. Overall, 90.8 % of patients with advanced-stage disease and LVI positivity experienced a relapse within 2 years after surgery, compared to 55.1 % of patients who did not have these factors (p < 0.01). Multivariate analysis showed that recurrence with symptoms (p < 0.01) and shorter time to recurrence (<24 months; p < 0.01) were independent prognostic factors after recurrence.

Conclusions: Although this study was retrospective and included some biases, patients with advanced-stage lung cancer and LVI positivity should be intensively followed up. Personalized follow-up programs should be considered for lung cancer patients who have undergone resection.

Citing Articles

Prognostic factors for relapse-free survival in stage IB-IIIA primary lung adenocarcinoma by epidermal growth factor receptor mutation status.

Isaka T, Ito H, Yokose T, Saito H, Adachi H, Murakami K BMC Cancer. 2022; 22(1):966.

PMID: 36085020 PMC: 9463865. DOI: 10.1186/s12885-022-10057-w.

Suppression of A549 cell proliferation and metastasis by calycosin via inhibition of the PKC‑α/ERK1/2 pathway: An in vitro investigation.

Cheng X, Gu J, Yuan J, Feng L, Jia X Mol Med Rep. 2015; 12(6):7992-8002.

PMID: 26498639 PMC: 4758323. DOI: 10.3892/mmr.2015.4449.

Factors affecting tumor recurrence after curative surgery for NSCLC: impacts of lymphovascular invasion on early tumor recurrence.

Park C, Lee I, Jang S, Lee J J Thorac Dis. 2014; 6(10):1420-8.

PMID: 25364519 PMC: 4215149. DOI: 10.3978/j.issn.2072-1439.2014.09.31.

References

Virgo K, McKirgan L, Caputo M, Mahurin D, Chao L, Caputo N . Post-treatment management options for patients with lung cancer. Ann Surg. 1995; 222(6):700-10. PMC: 1235018. DOI: 10.1097/00000658-199512000-00003. View

Mollberg N, Ferguson M . Postoperative surveillance for non-small cell lung cancer resected with curative intent: developing a patient-centered approach. Ann Thorac Surg. 2013; 95(3):1112-21. DOI: 10.1016/j.athoracsur.2012.09.075. View

Yoshino I, Yohena T, Kitajima M, Ushijima C, Nishioka K, Ichinose Y . Survival of non-small cell lung cancer patients with postoperative recurrence at distant organs. Ann Thorac Cardiovasc Surg. 2001; 7(4):204-9. View

Rubins J, Unger M, Colice G . Follow-up and surveillance of the lung cancer patient following curative intent therapy: ACCP evidence-based clinical practice guideline (2nd edition). Chest. 2007; 132(3 Suppl):355S-367S. DOI: 10.1378/chest.07-1390. View

Endo C, Sakurada A, Notsuda H, Noda M, Hoshikawa Y, Okada Y . Results of long-term follow-up of patients with completely resected non-small cell lung cancer. Ann Thorac Surg. 2012; 93(4):1061-8. DOI: 10.1016/j.athoracsur.2012.01.004. View

Korst R, Kansler A, Port J, Lee P, Altorki N . Accuracy of surveillance computed tomography in detecting recurrent or new primary lung cancer in patients with completely resected lung cancer. Ann Thorac Surg. 2006; 82(3):1009-15. DOI: 10.1016/j.athoracsur.2006.03.062. View

Sugimura H, Nichols F, Yang P, Allen M, Cassivi S, Deschamps C . Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection. Ann Thorac Surg. 2007; 83(2):409-17. DOI: 10.1016/j.athoracsur.2006.08.046. View

Martini N, Melamed M . Multiple primary lung cancers. J Thorac Cardiovasc Surg. 1975; 70(4):606-12. View

Walsh G, OConnor M, Willis K, Milas M, Wong R, Nesbitt J . Is follow-up of lung cancer patients after resection medically indicated and cost-effective?. Ann Thorac Surg. 1995; 60(6):1563-70; discussion 1570-2. DOI: 10.1016/0003-4975(95)00893-4. View

10.

Crino L, Weder W, Van Meerbeeck J, Felip E . Early stage and locally advanced (non-metastatic) non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2010; 21 Suppl 5:v103-15. DOI: 10.1093/annonc/mdq207. View

11.

Murthy S, Reznik S, Ogwudu U, Farver C, Arrossi A, Batizy L . Winning the battle, losing the war: the noncurative "curative" resection for stage I adenocarcinoma of the lung. Ann Thorac Surg. 2010; 90(4):1067-74. DOI: 10.1016/j.athoracsur.2010.04.108. View

12.

Nakagawa T, Okumura N, Ohata K, Igai H, Matsuoka T, Kameyama K . Postrecurrence survival in patients with stage I non-small cell lung cancer. Eur J Cardiothorac Surg. 2008; 34(3):499-504. DOI: 10.1016/j.ejcts.2008.05.016. View

13.

Sawabata N . Locoregional recurrence after pulmonary sublobar resection of non-small cell lung cancer: can it be reduced by considering cancer cells at the surgical margin?. Gen Thorac Cardiovasc Surg. 2012; 61(1):9-16. DOI: 10.1007/s11748-012-0156-6. View

14.

Lou F, Huang J, Sima C, Dycoco J, Rusch V, Bach P . Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance. J Thorac Cardiovasc Surg. 2012; 145(1):75-81. DOI: 10.1016/j.jtcvs.2012.09.030. View

15.

Taylor M, Nagji A, Bhamidipati C, Theodosakis N, Kozower B, Lau C . Tumor recurrence after complete resection for non-small cell lung cancer. Ann Thorac Surg. 2012; 93(6):1813-20. DOI: 10.1016/j.athoracsur.2012.03.031. View

16.

Goldstraw P, Crowley J, Chansky K, Giroux D, Groome P, Rami-Porta R . The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol. 2007; 2(8):706-14. DOI: 10.1097/JTO.0b013e31812f3c1a. View

17.

Shimada Y, Saji H, Yoshida K, Kakihana M, Honda H, Nomura M . Prognostic factors and the significance of treatment after recurrence in completely resected stage I non-small cell lung cancer. Chest. 2013; 143(6):1626-1634. DOI: 10.1378/chest.12-1717. View

18.

Ravdin P, Davis G . Prognosis of patients with resected non-small cell lung cancer: impact of clinical and pathologic variables. Lung Cancer. 2006; 52(2):207-12. DOI: 10.1016/j.lungcan.2006.01.016. View

19.

Westeel V, Choma D, Clement F, Woronoff-Lemsi M, Pugin J, Dubiez A . Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer. Ann Thorac Surg. 2000; 70(4):1185-90. DOI: 10.1016/s0003-4975(00)01731-8. View

20.

Colice G, Rubins J, Unger M . Follow-up and surveillance of the lung cancer patient following curative-intent therapy. Chest. 2003; 123(1 Suppl):272S-283S. DOI: 10.1378/chest.123.1_suppl.272s. View